Complete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma
Authors:
- Adrien ChauchetACAdrien Chauchet
- Anne-Sophie MichalletAMAnne-Sophie Michallet
- Françoise BergerFBFrançoise Berger
- Isabelle BedgedjianIBIsabelle Bedgedjian
- Eric DeconinckEDEric Deconinck
- Catherine SebbanCSCatherine Sebban
- Daciana AntalDADaciana Antal
- Hubert OrfeuvreHOHubert Orfeuvre
- Bernadette CorrontBCBernadette Corront
- Tony PetrellaTPTony Petrella
- Maya HaciniMHMaya Hacini
- Marie BouteloupMBMarie Bouteloup
Open Access
- 8 June 2012
- journal article
- research article
- Published by Springer Nature in Journal of Hematology & Oncology
- Vol. 5 (1) , 27
Abstract
Background: Extranodal nasal-type NK/T-cell lymphoma is a rare and severe disease. Considering the rarity of this lymphoma in Europe, we conducted a multicentric retrospective study on nasal-type NK/T cell lymphoma to determine the optimal induction strategy and identify prognostic factors.Methods: Thirty-six adult patients with nasal-type NK/T-cell lymphoma were recruited and assessed. In total, 80 % of patients were classified as having upper aerodigestive tract NK/T-cell lymphoma (UNKTL) and 20 % extra-upper aerodigestive tract NK/T-cell lymphoma (EUNKTL).Results: For advanced-stage disease, chemotherapy alone (CT) was the primary treatment (84 %vs.10 % for combined CT + radiation therapy (RT), respectively), while for early-stage disease, 50 % of patients received the combination of CT + RT and 50 % CT alone. Five-year overall survival (OS) and progression-free survival (PFS) rates were 39 % and 33 %. Complete remission (CR) rates were significantly higher when using CT + RT (90 %)versusCT alone (33 %) (p < 0.0001). For early-stage disease, CR rates were 37 % for CT aloneversus100 % for CT + RT. Quality of response was significantly associated with survival, with 5-year OS being 80 % for CR patientsversus0 % for progressive disease patients (p < 0.01).Conclusion: Early RT concomitantly or sequentially with CT led to improved patient outcomes, with quality of initial response being the most important prognosticator for 5-year OS.Keywords
This publication has 53 references indexed in Scilit:
- Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer/T‐cell or T‐cell lymphomaCancer, 2004
- Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic IndexBlood, 2004
- L-Asparaginase-Based Induction Therapy for Advanced Extranodal NK/T-Cell LymphomaInternational Journal of Hematology, 2003
- L-Asparaginase—Based Regimen in the Treatment of Refractory Midline Nasal/Nasal-Type T/NK-Cell LymphomaInternational Journal of Hematology, 2003
- Classification of cytotoxic T-cell and natural killer cell lymphomasSeminars in Hematology, 2003
- Early stage nasal NK/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modalityInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2002
- Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin’s Lymphoma Classification ProjectAnnals of Oncology, 2002
- Clinical features of peripheral T-cell lymphomas in 78 patients diagnosed according to the Revised European-American lymphoma (REAL) classificationEuropean Journal of Cancer, 2002
- Bone Marrow Involvement by Nasal NK Cell Lymphoma at Diagnosis Is UncommonAmerican Journal of Clinical Pathology, 2001
- Angiocentric nasal T/natural killer cell lymphoma: a single centre study of prognostic factors in 108 patientsClinical and Laboratory Haematology, 2000